Large-scale testing (Phase 3)Study completedNCT00883753
What this trial is testing
An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) Therapy
Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 934